Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

APVO

Aptevo Therapeutics Inc

4.55

Jun 26 • 04:00PM ET -0.03 (-0.66%)

Healthcare Biotechnology USA Nano NASD

Peers: APRE BCDA BIVI CALC CVM GOVX KAPA KPRX LNAI NEUP

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-203.74	Insider Own	0.06%	Shs Outstand	1.20M	Perf Week	-2.57%
Market Cap	5.67M	Forward P/E	-	EPS next Y	-12.12	Insider Trans	0.00%	Shs Float	1.15M	Perf Month	-5.99%
Enterprise Value	-4.44M	PEG	-	EPS next Q	-6.01	Inst Own	6.05%	Short Float	6.96%	Perf Quarter	0.89%
Income	-27.92M	P/S	-	EPS this Y	73.24%	Inst Trans	2.44%	Short Ratio	2.14	Perf Half Y	-75.22%
Sales	0.00M	P/B	0.47	EPS next Y	48.09%	ROA	-197.08%	Short Interest	0.08M	Perf YTD	-51.75%
Book/sh	9.65	P/C	0.39	EPS next 5Y	49.02%	ROE	-549.01%	52W High	61.56 -92.61%	Perf Year	-92.17%
Cash/sh	11.66	P/FCF	-	EPS past 3/5Y	- 89.05%	ROIC	-183.81%	52W Low	3.80 19.74%	Perf 3Y	-100.00%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	4.23% 5.60%	Perf 5Y	-100.00%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	99.36%	Oper. Margin	-	ATR (14)	0.27	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	3.36	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	43.41	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	3.36	EPS Q/Q	99.60%	SMA20	-5.18%	Beta	1.63	Target Price	25.50
Payout	-	Debt/Eq	0.38	Sales Q/Q	-	SMA50	-6.91%	Rel Volume	0.18	Prev Close	4.58
Employees	36	LT Debt/Eq	0.30	Earnings	May 07	SMA200	-65.72%	Avg Volume	37.42K	Price	4.55
IPO	Jul 20, 2016	Option/Short	No / Yes	EPS/Sales Surpr.	-14.46% -	Trades		Volume	6,860	Change	-0.66%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)